Your cart

There are no items in your shopping cart

PX 20350 - FXR agonist Cpd 22

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 2152

CAS [1198085-23-2]

MF C28H22Cl2F3N3O4
MW 592.39

  • Purity: 99%
  • Soluble in DMSO

PX 20350

Description

Potent farnesoid X receptor (FXR) agonist with enhanced affinity and efficacy (12 nM and 109% (compared to GW 4064)) in FXR FRET assay and full length FXR direct reporter (DR) assay (6 nM vs 30 nM for GW 4064). Cpd 22 showed a linear dose-dependent reduction in total plasma triglycerides and total plasma cholesterol.
Order
Size Unit Price Stock
5 mg €105.00 In Stock
25 mg €365.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €160.00 In Stock
2 x 25 mg €560.00 In Stock
Need more? Bulk Inquiry

Related Products

Axon ID Name Description From price
1266 GW 3965 hydrochloride Liver X receptor agonist €95.00
1749 WAY 362450 Farnesoid X receptor (FXR) agonist €125.00
1991 WYE 672 Liver X receptor (LXR) agonist €120.00
2357 LXR 623 Partial agonist of Liver X Receptor €95.00
2363 GSK 2033 The first potent cell-active LXR antagonist €105.00
3174 Obeticholic acid Potent and selective FXR agonist €60.00

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Newsletter
Give Feedback
 
Send E-mail

Customer Support

About Axon Medchem

Download Product Catalog

Download the Axon Ligands™ catalogue 2021 Spring Edition

Follow Us

© 2016 Axon Medchem. All Rights Reserved.

Send us a message

×

Contact Us

* Required Fields

Please wait...